| 22.1 CBT vs trauma‐ and anxiety‐related group psychoeducation (continuous) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 22.1.1 Primary: BPD symptom severity (continuous), at end of treatment |
1 |
50 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.26 [‐1.46, 0.94] |
| 22.1.2 Primary: BPD symptom severity (continuous), at 0‐6 months follow‐up |
1 |
50 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.39 [‐1.60, 0.82] |
| 22.1.3 Primary: BPD symptom severity (continuous), at 6‐12 months follow‐up |
1 |
50 |
Mean Difference (IV, Fixed, 95% CI) |
0.57 [‐0.48, 1.62] |
| 22.1.4 Primary: psychosocial functioning (continuous), at end of treatment |
1 |
50 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.64 [‐5.76, 4.48] |
| 22.1.5 Primary: psychosocial functioning (continuous), at 0‐6 months follow‐up |
1 |
50 |
Mean Difference (IV, Fixed, 95% CI) |
‐1.23 [‐6.94, 4.48] |
| 22.1.6 Primary: psychosocial functioning (continuous), at 6‐12 months follow‐up |
1 |
50 |
Mean Difference (IV, Fixed, 95% CI) |
0.61 [‐5.00, 6.22] |
| 22.1.7 Secondary: depression (continuous), at end of treatment |
1 |
50 |
Mean Difference (IV, Fixed, 95% CI) |
0.76 [‐8.20, 9.72] |
| 22.1.8 Secondary: depression (continuous), at 0‐6 months follow‐up |
1 |
50 |
Mean Difference (IV, Fixed, 95% CI) |
3.13 [‐4.05, 10.31] |
| 22.1.9 Secondary: depression (continuous), at 6‐12 months follow‐up |
1 |
50 |
Mean Difference (IV, Fixed, 95% CI) |
0.77 [‐7.08, 8.62] |
| 22.2 CBT vs trauma‐ and anxiety‐related group psychoeducation, secondary: attrition (dichotomous), at end of treatment |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 22.3 CBT vs interpersonal psychotherapy (IPT) (continuous) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 22.3.1 Primary: psychosocial functioning (continuous), at end of treatment |
1 |
26 |
Mean Difference (IV, Fixed, 95% CI) |
‐5.30 [‐12.36, 1.76] |
| 22.3.2 Secondary: depression (continuous), at end of treatment |
1 |
26 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.40 [‐4.72, 3.92] |
| 22.4 CBT vs IPT, secondary: attrition (dichotomous), at end of treatment |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 22.5 CBT vs Rogerian supportive therapy (continuous) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 22.5.1 Primary: self‐harm (continuous), end of treatment |
1 |
38 |
Mean Difference (IV, Fixed, 95% CI) |
0.74 [‐0.03, 1.51] |
| 22.5.2 Primary: self‐harm (continuous), at 6‐12 months follow‐up |
1 |
21 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.63 [‐1.75, 0.49] |
| 22.5.3 Primary: suicide‐related outcomes (continuous), at end of treatment |
1 |
38 |
Mean Difference (IV, Fixed, 95% CI) |
0.69 [‐2.60, 3.98] |
| 22.5.4 Primary: suicide‐related outcomes (continuous), at 6‐12 months follow‐up |
1 |
21 |
Mean Difference (IV, Fixed, 95% CI) |
‐2.43 [‐6.14, 1.28] |
| 22.5.5 Primary: psychosocial functioning (continuous), at end of treatment |
1 |
38 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.43 [‐1.31, 0.45] |
| 22.5.6 Primary: psychosocial functioning (continuous), at 6‐12 months follow‐up |
1 |
21 |
Mean Difference (IV, Fixed, 95% CI) |
‐0.98 [‐2.02, 0.06] |
| 22.5.7 Secondary: impulsivity (continuous), at end of treatment |
1 |
38 |
Mean Difference (IV, Fixed, 95% CI) |
‐1.01 [‐3.85, 1.83] |
| 22.5.8 Secondary: impulsivity (continuous), at 6‐12 months follow‐up |
1 |
21 |
Mean Difference (IV, Fixed, 95% CI) |
‐2.18 [‐5.91, 1.55] |
| 22.5.9 Secondary: depression (continuous), at end of treatment |
1 |
38 |
Mean Difference (IV, Fixed, 95% CI) |
1.04 [‐5.59, 7.67] |
| 22.5.10 Secondary: depression (continuous), at 6‐12 months follow‐up |
1 |
21 |
Mean Difference (IV, Fixed, 95% CI) |
‐5.15 [‐9.38, ‐0.92] |
| 22.6 CBT vs Rogerian supportive therapy, secondary: attrition (dichotomous), end of treatment |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 22.7 MACT (Manual‐assisted Cognitive Therapy) vs MACT + therapeutic assessment (MACT + TA) (continuous) |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 22.7.1 Primary: BPD symptom severity (continuous), at end of treatment |
1 |
16 |
Mean Difference (IV, Random, 95% CI) |
‐3.75 [‐14.17, 6.67] |
| 22.7.2 Primary: self‐harm (continuous), at end of treatment |
1 |
16 |
Mean Difference (IV, Random, 95% CI) |
1.75 [‐18.71, 22.21] |
| 22.7.3 Primary: suicide‐related outcomes (continuous), at end of treatment |
1 |
16 |
Mean Difference (IV, Random, 95% CI) |
‐0.63 [‐17.71, 16.45] |
| 22.7.4 Secondary: affective instability (continuous), at end of treatment |
1 |
16 |
Mean Difference (IV, Random, 95% CI) |
‐5.25 [‐12.10, 1.60] |
| 22.7.5 Secondary: interpersonal problems (continuous), at end of treatment |
1 |
16 |
Mean Difference (IV, Random, 95% CI) |
‐0.50 [‐11.24, 10.24] |
| 22.7.6 Secondary: identity disturbance (continuous), at end of treatment |
1 |
16 |
Mean Difference (IV, Random, 95% CI) |
‐4.88 [‐14.98, 5.22] |
| 22.8 MACT vs MACT + TA, secondary: attrition (dichotomous), at end of treatment |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 22.9 Meta‐Cognitive training for BPD (B‐MCT) vs progressive muscle relaxation training (PMR) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
| 22.9.1 Primary: BPD symptom severity (continuous), at end of treatment |
1 |
49 |
Mean Difference (IV, Fixed, 95% CI) |
‐1.80 [‐4.97, 1.37] |
| 22.9.2 Primary: BPD symptom severity (continuous), at 0‐6 months follow up |
1 |
39 |
Mean Difference (IV, Fixed, 95% CI) |
‐3.60 [‐7.16, ‐0.04] |
| 22.9.3 Secondary: depression (continuous), at end of treatment |
1 |
54 |
Mean Difference (IV, Fixed, 95% CI) |
‐3.20 [‐9.91, 3.51] |
| 22.9.4 Secondary: depression (continuous), at 0‐6 months follow‐up |
1 |
47 |
Mean Difference (IV, Fixed, 95% CI) |
8.50 [2.03, 14.97] |
| 22.10 B‐MCT vs progressive muscle relaxation (PMR) training + TAU (dichotomous). Secondary: attrition (dichotomous), at end of treatment |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
| 22.11 MOTR (Motive‐Oriented Therapeutic Relationship) vs Good Psychiatric Management (GPM) (continuous) |
2 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
| 22.11.1 Primary: BPD symptom severity (continuous), at end of treatment |
1 |
74 |
Std. Mean Difference (IV, Random, 95% CI) |
0.07 [‐0.39, 0.53] |
| 22.11.2 Primary: psychosocial functioning (continuous), at end of treatment |
2 |
99 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.45 [‐0.85, ‐0.05] |
| 22.11.3 Secondary: interpersonal problems (continuous), at end of treatment |
2 |
99 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.56 [‐0.97, ‐0.16] |
| 22.12 MOTR vs (GPM), secondary: attrition (dichotomous), at end of treatment |
2 |
110 |
Risk Ratio (M‐H, Random, 95% CI) |
0.61 [0.26, 1.41] |
